Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

Blood samples

The blood will be sampled in order to be tested in Immunology, twice, the day they sign their agreement and six months after in case of positive myelin pentamer test (at inclusion and 6 months after the inclusion).

BIOLOGICAL

Blood samples

The blood will be sampled in order to be tested in Immunology, once, the day they sign their agreement (at the inclusion)

Trial Locations (1)

33076

Service de Neurologie - Tripode - Hôpital Pellegrin, Bordeaux

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Merck Serono International SA

INDUSTRY

collaborator

ADERA

UNKNOWN

lead

University Hospital, Bordeaux

OTHER

NCT02142764 - Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter